Cancer screening tests, cancer diagnoses during COVID-19 pandemic

What The Study Did:
The number of patients undergoing cancer screening tests and of subsequent cancer diagnoses during the COVID-19 pandemic in the largest health care system in the northeastern United States was assessed in this study.

Authors: 
Toni K. Choueiri, M.D., of the Dana-Farber Cancer Institute and Quoc-Dien Trinh, M.D., of Brigham and Women’s Hospital in Boston, are the corresponding authors.

To access the embargoed study:
Visit our For The Media website at this link
https://media.jamanetwork.com/ 

(doi:10.1001/jamaoncol.2020.7600)

Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

###

Media advisory:
The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article 
This link will be live at the embargo time
https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.7600?guestAccessKey=8e9733f4-229b-4616-a1fe-169ee2e23abd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011421

Media Contact
JAMA Network Media Relations
[email protected]

Comments